Venmax Drugs And Pharmaceuticals Board of Directors
Get the latest insights into the leadership at Venmax Drugs And Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Venkata Rao Sadhanala | Whole Time Director |
| Mrs. Dakshita Jain | Addnl.Non Exe.Independent Director |
| Mr. Reddeppa Gundluru | Non Exe.Non Ind.Director |
| Mr. Swapneshwar Mishra | Non Exe.Non Ind.Director |
| Mr. Dasi Reddy Rakesh | Non Exe.Non Ind.Director |
Venmax Drugs And Pharmaceuticals Share price
VENMAX
27.27
1.43 (-4.98%)Last updated on 4 Nov, 2025 | 11:16 IST
BUYSELL
Today's High
29.94
Today's Low
27.27
52 Week Low
6.27
52 Week High
36.96
The current prices are delayed, login to your account for live prices
LoginVenmax Drugs And Pharmaceuticals FAQs
The board at Venmax Drugs And Pharmaceuticals consists of experienced professionals, including Mr. Venkata Rao Sadhanala , Mrs. Dakshita Jain , and others, overseeing the company’s strategic and corporate governance.
Directors at Venmax Drugs And Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Venkata Rao Sadhanala is the current chairman at Venmax Drugs And Pharmaceuticals.
Executive directors at Venmax Drugs And Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Venmax Drugs And Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Venmax Drugs And Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.